GlassScriptPhysician profile
Paul Ulrich
NPI 1285291609
$10,901.46
in general payments reported to CMS, 2019-2025
22 companies · $4,442 in 2025
The $4,442 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2021: $97.38 · 2022: $812 · 2023: $13.09 · 2024: $4,829 · 2025: $4,442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Consulting Fee: $1,500 · Food and Beverage: $1,470 · Travel and Lodging: $993 · Education: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,469.98 |
| Travel and Lodging | $992.92 |
| Education | $321.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,562.41 | 2022-2025 | Pico 14 |
| Encore Medical, LP | $2,558.63 | 2024-2025 | Djo Surgical |
| Medwest Associates | $708.00 | 2019 | |
| Medical Device Business Services, INC. | $321.49 | 2024 | |
| Stryker Corporation | $206.21 | 2022-2024 | Triathlon |
| Depuy Synthes Sales INC. | $184.19 | 2024 | Attune |
| Boston Scientific Corporation | $163.35 | 2021-2022 | |
| Omnilife Science, INC | $162.29 | 2024 | Various Products |
| Solventum Corporation | $155.97 | 2025 | V.A.C.Ulta, Prevena |
| Linkbio Corp | $136.95 | 2024 | |
| Abbvie INC. | $124.09 | 2022 | |
| Biocomposites INC | $120.62 | 2024 | |
| Si-Bone, INC. | $118.41 | 2022 | |
| Zimmer Biomet Holdings, INC. | $88.18 | 2024 | Mymobility Platform |
| Lightbody Medical Technologies INC | $83.23 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $59.00 | 2024 | |
| Heron Therapeutics, INC. | $32.17 | 2021 | |
| Peerless Surgical INC. | $31.75 | 2025 | |
| Medtronic, INC. | $25.01 | 2025 | Aquamantys(Tm) |
| Pacira Pharmaceuticals Incorporated | $24.75 | 2025 | Exparel, Iovera |
| Fidia Pharma USA INC. | $21.67 | 2025 | Hymovis |
| Sanofi-Aventis U.S. LLC | $13.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Ulrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.